GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Haleos Labs Ltd

Haleos Labs subsidiary appoints Annapragada & Co. as Cost Auditors

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 05 Aug 2026, 03:15 PM IST  ·  BSE ID: 5ecfabe0-0147-4f01-aeb2-ff117789dcb6
View Original BSE Filing (PDF)
💡
In Simple Terms
Haleos Labs' subsidiary has appointed auditors for its costs and added a new director to its board.
🤖 AI Summary
  • Mahi Drugs Private Limited appointed Annapragada & Co. as Cost Auditors for FY 2026-27.
  • Mr. Vincent P. Asrao appointed as Nominee Director of the subsidiary.
  • Mr. M. Madhu Rao ceases to be Nominee Director effective August 5, 2026.
  • Appointment effective from August 5, 2026, as per Companies Act, 2013.
🏢 How This Affects the Company
⚙️
Operational Impact
The appointment of cost auditors is a routine governance measure to ensure compliance with financial regulations for the subsidiary.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding these appointments.
👤
Who Is Affected
Shareholders are indirectly affected by standard corporate governance compliance within the subsidiary's operations.
🔍
Management Signal
Management is ensuring regulatory compliance and proper board oversight at the subsidiary level.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Subsequent financial reports for Mahi Drugs Private Limited.
Disclosure of any findings from the cost audit.
Updates on Mr. Vincent P. Asrao's tenure as Nominee Director.
LOW RISK Routine governance appointments with no immediate financial implications.
💡 Investor Takeaway
Haleos Labs' material subsidiary, Mahi Drugs Private Limited, appointed Annapragada & Co. as Cost Auditors for 2026-27 and Mr. Vincent P. Asrao as Nominee Director.
❓ Frequently Asked Questions
Who has been appointed as the Cost Auditor for Mahi Drugs Private Limited for 2026-27?
Annapragada & Co. has been appointed as the Cost Auditor for Mahi Drugs Private Limited for the year 2026-27.
Who is the new Nominee Director at Mahi Drugs Private Limited?
Mr. Vincent P. Asrao has been appointed as the Nominee Director, nominated by ChemWerth Inc., effective August 5, 2026.
Who did Mr. Vincent P. Asrao replace as Nominee Director?
Mr. Vincent P. Asrao has been appointed in place of Mr. M. Madhu Rao, who ceases to be Nominee Director.
Under which act were the cost auditors appointed?
The cost auditors were appointed pursuant to Section 148 of the Companies Act, 2013, read with the Companies (Audit and Auditors) Rules, 2014.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.